Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.
It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
In research on the swine flu virus it has been seen that the virus may seem new, but it has old relatives. An influenza virus which was pandemic in 1918 is seen to be very closely related, structurally speaking, to the H1N1 swine flu vaccine. This virus has the dubious distinction of having claimed between 40 million to 100 million lives in the flu wave of 1918.
Custom Spine announced today that it has received FDA clearance to market PATHWAY ACIF, an anterior cervical interbody spacer. This cervical interbody device compliments the company's low-profile anterior cervical plate system, Regent ACP, which was released this past November.
When it comes to some diseases prevention still is better than cure and swine flu is one such disease. The sheer global panic that gripped nations last year is hard to forget. The PanvaxH1N1 vaccine is specifically manufactured to target the influenza (A) H1N1 strain known more popularly as swine flu. Getting the flu shots may be crucial in prevention of spread of the highly contagious disease. Health officials say that the H1N1 strain of flu is still circulating but at low levels.
BioSante Pharmaceuticals, Inc. today announced positive GVAX AML Vaccine results and BioSante’s receipt of Orphan Drug designation from the FDA’s Office of Orphan Products Development for GVAX AML Vaccine in the treatment of acute myeloid leukemia. This Orphan Drug designation is the second GVAX cancer vaccine from BioSante to secure FDA orphan drug designation.
Most people want better access to health care for themselves and their family, however a major obstacle in achieving this is the time and hassle involved in seeing a doctor. Many find the whole process discouraging.
University of California, Davis, scientists are helping rice farmers in Uruguay stop polluting their waterways -- including drinking-water sources and a globally valuable nature reserve.
Swine flu a form of influenza, became a major health scare assuming pandemic proportions starting in Mexico early last year. There were 37,000 confirmed cases in Australia with 5,000 hospitalizations, 700 admissions in intensive care units and 191 deaths.
A new study published in the April issue of Radiology suggests that chest x-rays may play an important role in the diagnosis and treatment of H1N1 influenza by predicting which patients are likely to become sicker.
The WHO on Friday announced "it had delivered the first doses of H1N1 [swine flu] vaccine to Cuba, and a dozen countries in Africa would receive millions of doses in coming weeks," Reuters reports.
A new understanding of a certain cell in the immune system may help guide scientists in creating better flu vaccines, report researchers from the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston.
Vical Incorporated announced today that the U.S. Navy, through the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., has awarded Vical a contract to conduct a Phase 1 clinical trial of the company's Vaxfectin®-formulated DNA vaccine against A/H1N1 pandemic influenza (swine flu).
A study to be published in the British Medical Journal (BMJ) today has found 11 percent of pregnant women admitted to intensive care units (ICU) with 2009 A/H1N1 (swine flu) died, with 12 percent of babies born to them dying from complications. None of the mothers had been immunised against seasonal flu.
Researchers at the University of Nebraska Medical Center found an Infrared Thermal Detection System to be a fast and effective fever screening tool in clinical settings during the H1N1 influenza pandemic. The ITDS detected fever in patients through split-second, non-contact skin temperature measurements.
Pressure BioSciences, Inc. today announced that five presentations on the advantages of pressure cycling technology (PCT) in the preparation, processing, identification, and quantification of proteins were made at last week's annual meeting of US HUPO (Human Proteomics Organization) in Denver, Colorado.
Activeion Cleaning Solutions LLC, Rogers, MN USA is proud to announce its new European subsidiary, Activeion (Europe) GmbH. Activeion (Europe) GmbH will distribute and market the ionator EXP™ throughout Europe, the Middle East and Africa. Activeion's ionator EXP™ is a handheld, on-demand, completely chemical-free cleaning tool that activates and converts tap water into ionised water, a powerful dirt-removing and bacteria-killing product.
With almost half of respondents saying they believe a sneeze travels eight feet or more, one might think you would be sick all the time. But a recent national survey of 1,017 U.S. adult men and women (age 18+) conducted by Matrixx Initiatives, Inc., maker of Zicam, found a majority of Americans polled surprisingly saw this cold and flu season as "about the same" (42%) or only "slightly worse" (21%) from last year, despite all the hype this past fall around H1N1.
In its 2009 Corporate Responsibility Report published online today, GSK reiterated its commitment to running its business responsibly and to making the company more responsive, more flexible and more open to the expectations of society.
"Educationally relevant health disparities" are key drivers of the achievement gap, "but they are largely overlooked," Charles Basch, the Richard March Hoe Professor of Health Education at Teachers College, Columbia University, said at a recent panel discussion at the College.
Treating virulent influenza, sepsis, and other potentially deadly infections long has focused on looking for ways to kill viruses and bacteria. But new research from the University of Utah and Utah State University shows that modulating the body's own overeager inflammatory response to infection may help save more lives.
On the heels of the recent H1N1 pandemic, the International Centre for Infectious Diseases is providing online planning tools to help non-profit organizations develop pandemic flu plans. It is urging vigilance against future waves of the virus, and advises organizations to take action now to plan for events that could threaten the delivery of service to their clients.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.